Skip to content

Orientation Agnosia: Clinical and Anatomical Study

Orientation Agnosia: Neuropsychological Evaluation, Associated Symptoms, Clinical and Anatomical Correlations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01304576
Acronym
AGNORIENT
Enrollment
34
Registered
2011-02-25
Start date
2010-09-30
Completion date
2013-12-31
Last updated
2014-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Lesions, Cerebrovascular Disorders

Keywords

stroke, parietal lesions

Brief summary

The area of the brain responsible of visuospatial processing data and more specifically the orientation of an object or image is located in parietal lobe, especially on the right side. A dysfunction of this region would result in a disorder of recognition of the orientation of objects and images that the investigators call orientation agnosia. Several isolated cases are reported in the literature but to the investigators knowledge deficit has never been systematically searched, or put into perspective compared to other neuropsychological deficits. Moreover, the precise location of the lesion responsible for such a disorder remains uncertain. The objectives of this study are (1) detect the existence of orientation agnosia in case of right parietal lesion, and (2) to improve the understanding of such a deficit allowing better management of this disorder.

Detailed description

Idem

Interventions

BEHAVIORALNeuropsychological testing

Experimental test about orientation agnosia and standard neuropsychological tests.

OTHERMRI

Cerebral MRI

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 80 years * french language * right parietal lesion on cerebral imaging (CT-scan is sufficient), including stroke,arterial malformation, isolated tumoral lesion * informed consent

Exclusion criteria

* previous neurological history except non complicated migraine and stabilized epilepsia without seizure since 5 years * previous psychiatric history except depression without hospitalization \> one week or anxiety with maximum one anxiolytic treatment * drug or alcohol abuse * severe cranial traumatism * other severe chronic pathology * psychotropic medication other than a hypnotic or an anxiolytic at low doses without dose modification for at least one month * visual impairment * motor or sensory deficit sufficient to render impossible neuropsychological tests * patient without judicial or administrative liberty * measure of legal protection or no capable to express their consent * pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
orientation agnosia evaluation1 week to 6 months (average)orientation agnosia test

Secondary

MeasureTime frame
associated clinical symptoms especially apraxia1 week to 6 months (average)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026